Development and clinical evaluation of non-viral genome specific targeted CAR T cells in relapsed/refractory B-cell non-Hodgkin lymphoma
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, Wei Li, Yue Tian, Guoqing Wei, Linjie Zhang, Kui Zhao, Yalei Qi, Binghe Tan, Mingming Zhang, Yi Li, Qiliang Tian, Chunqian Fang, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang
doi: https://doi.org/10.1101/2020.09.22.20199786
Jiqin Zhang
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
3Bioray Laboratories Inc., Shanghai, China
Yongxian Hu
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Jiaxuan Yang
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Wei Li
3Bioray Laboratories Inc., Shanghai, China
Yue Tian
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Guoqing Wei
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Linjie Zhang
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Kui Zhao
4PETCT Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Yalei Qi
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Binghe Tan
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Mingming Zhang
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Yi Li
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Qiliang Tian
3Bioray Laboratories Inc., Shanghai, China
Chunqian Fang
3Bioray Laboratories Inc., Shanghai, China
Yuxuan Wu
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Dali Li
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Bing Du
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
Mingyao Liu
1Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
He Huang
2Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data that supported the findings of this study are available from the corresponding author upon reasonable request.
Posted September 23, 2020.
Development and clinical evaluation of non-viral genome specific targeted CAR T cells in relapsed/refractory B-cell non-Hodgkin lymphoma
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, Wei Li, Yue Tian, Guoqing Wei, Linjie Zhang, Kui Zhao, Yalei Qi, Binghe Tan, Mingming Zhang, Yi Li, Qiliang Tian, Chunqian Fang, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang
medRxiv 2020.09.22.20199786; doi: https://doi.org/10.1101/2020.09.22.20199786
Development and clinical evaluation of non-viral genome specific targeted CAR T cells in relapsed/refractory B-cell non-Hodgkin lymphoma
Jiqin Zhang, Yongxian Hu, Jiaxuan Yang, Wei Li, Yue Tian, Guoqing Wei, Linjie Zhang, Kui Zhao, Yalei Qi, Binghe Tan, Mingming Zhang, Yi Li, Qiliang Tian, Chunqian Fang, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang
medRxiv 2020.09.22.20199786; doi: https://doi.org/10.1101/2020.09.22.20199786
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4028)
- Geriatric Medicine (379)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (358)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (563)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6469)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)